Skip to main content

. 1972 Jan 22;1(5794):220–221. doi: 10.1136/bmj.1.5794.220

Hyperaldosteronism from adrenal carcinoma.

R V Brooks, D Felix-Davies, M R Lee, P W Robertson

PMCID: PMC1789213 PMID: 5058733

220

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Brunner H. R., Baer L., Sealey J. E., Ledingham J. G., Laragh J. H. The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest. 1970 Nov;49(11):2128–2138. doi: 10.1172/JCI106430. [DOI] [PMC free article] [PubMed] [Google Scholar]
FOYE L. V., Jr, FEICHTMEIR T. V. Adrenal cortical carcinoma producing solely mineralocorticoid effect. Am J Med. 1955 Dec;19(6):966–975. doi: 10.1016/0002-9343(55)90163-7. [DOI] [PubMed] [Google Scholar]
LIPSETT M. B., WILSON H. Adrenocortical cancer: steroid biosynthesis and metabolism evaluated by urinary metabolites. J Clin Endocrinol Metab. 1962 Sep;22:906–915. doi: 10.1210/jcem-22-9-906. [DOI] [PubMed] [Google Scholar]
Spark R. F., Melby J. C. Aldosteronism in hypertension. The spironolactone response test. Ann Intern Med. 1968 Oct;69(4):685–691. doi: 10.7326/0003-4819-69-4-685. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES